RxDoctor Payments Data

Kimberly Thomsen

Rheumatology · Marquette, MINPI 1942309778

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $672 and has fallen 85.5% since, to $97 in 2023. That places this record below the midpoint for rheumatology clinicians in MI, where the typical reported total is $1,854.

$2,056in general payments, 2019–2025

Across 118 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$276
  • Pfizer$225
  • Novartis$196
  • UCB, Inc.$179
  • AstraZeneca$173
  • Genentech USA, Inc.$170
  • plus $838 from 17 others

What the payments were for

  • Food & beverage$1,91493%
  • Education$1437%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,056 in reported general payments places this provider in the 50th percentile of 195 rheumatology providers in Michigan.

See all rheumatology providers in Michigan →

Other rheumatology in Marquette

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →